Gaining MOMENTUM against anaemic myelofibrosis

被引：0
|
作者：
Ikeda, Kazuhiko [1 ]
Ueda, Koki [1 ]
机构：
[1] Fukushima Med Univ, Dept Blood Transfus & Transplantat Immunol, Sch Med, Fukushima 9601295, Japan
来源：
LANCET | 2023年 / 401卷 / 10373期
关键词：
MOMELOTINIB; RUXOLITINIB; INHIBITOR;
D O I：
10.1016/s0140-6736(23)00171-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 8 条
  • [1] Maintaining MOMENTUM in myelofibrosis
    Kremyanskaya, Marina
    Marcellino, Bridget K.
    LANCET HAEMATOLOGY, 2023, 10 (09): : E697 - E699
  • [2] Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study
    Mesa, Ruben A.
    Harrison, Claire
    Palmer, Jeanne M.
    Gupta, Vikas
    Mclornan, Donal P.
    Mcmullin, Mary Frances
    Kiladjian, Jean-Jacques
    Foltz, Lynda
    Platzbecker, Uwe
    Fox, Maria Laura
    Mead, Adam J.
    Ross, David M.
    Oh, Stephen T.
    Perkins, Andrew Charles
    Leahy, Michael F.
    Kawashima, Jun
    Ro, Sunhee
    Donahue, Rafe
    Gorsh, Boris
    Deheshi, Samineh
    Verstovsek, Srdan
    HEMASPHERE, 2023, 7 (11): : E966
  • [3] Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM
    Masarova, Lucia
    Verstovsek, Srdan
    Liu, Tom
    Rao, Sumati
    Sajeev, Gautam
    Fillbrunn, Mirko
    Simpson, Ryan
    Li, Weilong
    Yang, Joseph
    Le Lorier, Yvette
    Gorsh, Boris
    Signorovitch, James
    FUTURE ONCOLOGY, 2024, 20 (30) : 2259 - 2270
  • [4] MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic
    Verstovsek, Srdan
    Chen, Chih-Cheng
    Egyed, Miklos
    Ellis, Martin
    Fox, Laura
    Goh, Yeow T.
    Gupta, Vikas
    Harrison, Claire
    Kiladjian, Jean-Jacques
    Lazaroiu, Mihaela C.
    Mead, Adam
    McLornan, Donal
    McMullin, Mary F.
    Oh, Stephen T.
    Perkins, Andrew
    Platzbecker, Uwe
    Scheid, Christof
    Vannucchi, Alessandro
    Yoon, Sung-Soo
    Kowalski, Mark M.
    Mesa, Ruben A.
    FUTURE ONCOLOGY, 2021, 17 (12) : 1449 - 1458
  • [5] Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) [MOMENTUM]
    Gerds, Aaron
    Verstovsek, Srdan
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S340 - S340
  • [6] MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor
    Mesa, Ruben
    Gerds, Aaron
    Vannucchi, Alessandro
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Donahue, Rafe
    Kawashima, Jun
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S339 - S340
  • [7] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
    Verstovsek, Srdan
    Gerds, Aaron T.
    Vannucchi, Alessandro M.
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew T.
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela C.
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung -Soo
    Gupta, Vikas
    Kiladjian, Jean -Jacques
    Granacher, Nikki
    Lee, Sung-Eun
    Ocroteala, Luminita
    Passamonti, Francesco
    Harrison, Claire N.
    Klencke, Barbara J.
    Ro, Sunhee
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    LANCET, 2023, 401 (10373) : 269 - 280
  • [8] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
    Gerds, Aaron T.
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    Al-Ali, Haifa Kathrin
    Lavie, David
    Kuykendall, Andrew
    Grosicki, Sebastian
    Iurlo, Alessandra
    Goh, Yeow Tee
    Lazaroiu, Mihaela C.
    Egyed, Miklos
    Fox, Maria Laura
    McLornan, Donal
    Perkins, Andrew
    Yoon, Sung-Soo
    Gupta, Vikas
    Kiladjian, Jean-Jacques
    Granacher, Nikki
    Lee, Sung-Eun
    Ocroteala, Luminita
    Passamonti, Francesco
    Harrison, Claire N.
    Oh, Stephen
    Klencke, Barbara J.
    Yu, Jing
    Donahue, Rafe
    Kawashima, Jun
    Mesa, Ruben
    LANCET HAEMATOLOGY, 2023, 10 (09): : E735 - E746
1